Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats

International Journal of Andrology

Volumn 35, Issue 4, 2012, Pages 601-607

  Sun, C ^a   Lin, H ^a   Yu, W ^a   Li, X ^a,c   Chen, Y ^a   Qiu, X ^a   Wang, R ^b   Dai, Y ^a  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Nantong Hospital of Traditional Chinese Medicine   (China)

Author keywords

Diabetes; Erectile dysfunction; Mesenchymal stem cells; Neurotrophic; Paracrine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; CONTROLLED STUDY; DORSAL ROOT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACAVERNOUS PRESSURE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEUROTROPISM; NONHUMAN; PENIS; PRIORITY JOURNAL; TREATMENT OUTCOME; UROGENITAL SYSTEM PARAMETERS;

ANIMALS; BONE MARROW CELLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL- AND TISSUE-BASED THERAPY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ERECTILE DYSFUNCTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NERVE GROWTH FACTOR; NERVE REGENERATION; PENIS; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863870153     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2012.01250.x     Document Type: Article

References (30)

1. Albersen M, Fandel TM, Lin GT, Wang G, Banie L, Lin CS & Lue TF. (2010) Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med, 7, 3331-3340.
2. Albersen M, Fandel TM, Zhang H, Banie L, Lin G, De Ridder D, Lin CS & Lue TF. (2011) Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. Eur Urol, 59, 286-296.
3. Azadzoi KM & Saenz de Tejada I. (1992) Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol, 148, 1587-1591.
4. Bakircioglu ME, Lin CS, Fan P, Sievert KD, Kan YW & Lue TF. (2001) The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol, 165, 2103-2109.
5. Bella AJ, Lin G, Lin CS, Hickling DR, Morash C & Lue TF. (2009) Nerve growth factor modulation of the cavernous nerve response to injury. J Sex Med, 6 Suppl 3, 347-352.
6. Bivalacqua TJ, Deng WW, Kendirci M, Usta MF, Robinson C, Taylor BK et al. (2007) Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol, 292, H1278-H1290.
7. Carson CC, Burnett AL, Levine LA & Nehra A. (2002) The efficacy of sildenafil citrate (viagra) in clinical populations: an update. Urology, 60, 12-27.
8. Cellek S, Rodrigo J, Lobos E, Fernandez P, Serrano J & Moncada S. (1999) Selective nitrergic neurodegeneration in diabetes mellitus - A nitric oxide-dependent phenomenon. Br J Pharmacol, 128, 1804-1812.
9. De Young L, Yu D, Bateman RM & Brock GB. (2004) Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction. J Androl, 25, 830-836.
10. Fall PA, Izikki M, Tu L, Swieb S, Giuliano F, Bernabe J et al. (2009) Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunction. Eur Urol, 56, 716-725.
11. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ & McKinlay JB. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol, 151, 54-61.
12. Garcia MM, Fandel TM, Lin GT, Shindel AW, Banie L, Lin CS et al (2010) Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med, 7, 89-98.
13. Gholami SS, Rogers R, Chang J, Ho HC, Grazziottin T, Lin CS et al (2003) The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol, 169, 1577-1581.
14. Gur S, Kadowitz PJ & Hellstrom WJ. (2010) A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats. J Sex Med, 7, 3341-3350.
15. Hakim LS & Goldstein I. (1996) Diabetic sexual dysfunction. Endocrinol Metab Clin North Am, 25, 379-400.
16. Hsieh PS, Bochinski DJ, Lin GT, Nunes L, Lin CS & Lue TF. (2003) The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int, 92, 470-475.
17. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41-49.
18. Kendirci M, Trost L, Bakondi B, Whitney MJ, Hellstrom WJ & Spees JL. (2011) Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury. J Urol, 184, 1560-1566.
19. Klotz L. (2004) Cavernosal nerve mapping: current data and applications. BJU Int, 93, 9-13.
20. Lin G, Chen KC, Hsieh PS, Yeh CH, Lue TF & Lin CS. (2003) Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia. BJU Int, 92, 631-635.
21. Lin G, Shindel AW, Fandel TM, Bella AJ, Lin CS & Lue TF. (2010) Neurotrophic effects of brain-derived neurotrophic factor and vascular endothelial growth factor in major pelvic ganglia of young and aged rats. BJU Int, 105, 114-120.
22. Malavige LS & Levy JC. (2009) Erectile dysfunction in diabetes mellitus. J Sex Med, 6, 1232-1247.
23. Martinez-Jabaloyas JM, Gil-Salom M, Villamon-Fort R, Pastor-Hernandez F, Martinez-Garcia R & Garcia-Sisamon F. (2001) Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol, 40, 641-646. discussion 647.
24. Moore CR & Wang R. (2006) Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl, 8, 675-684.
25. Qiu X, Lin H, Wang Y, Yu W, Chen Y, Wang R et al. (2011) Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocin-induced diabetic rats. J Sex Med, 8, 427-436.
26. Qiu X, Sun C, Yu W, Lin H, Sun Z, Chen Y et al. (2012) Combined strategy of mesenchymal stem cells injection with vegf gene therapy for the treatment of diabetes associated erectile dysfunction. J Androl, 33, 37-44.
27. Rendell MS, Rajfer J, Wicker PA & Smith MD. (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil diabetes study group. JAMA, 281, 421-426.
28. Saenz de Tejada I, Blanco R, Goldstein I, Azadzoi K, de las Morenas A, Krane RJ et al. (1988) Cholinergic neurotransmission in human corpus cavernosum I. Responses of isolated tissue. Am J Physiol, 254, H459-H467.
29. Togel F & Westenfelder C. (2011) The role of multipotent marrow stromal cells (MSCs) in tissue regeneration. Organogenesis, 7, 96-100.
30. Wen ZZ, Zheng SX, Zhou CQ, Wang JF & Wang T. (2011) Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med, 15, 1032-1043.